These effects, together with a previous report displaying that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,two help the idea of targeting ACKR3 as a singular strategy to modulate the opioid process, which could open new therapeutic avenues for opioid-relevant Conditions. Disclaimer: The above mentioned is a https://jamesb814hez4.wiki-jp.com/user